Opaleye Management as of June 30, 2020
Portfolio Holdings for Opaleye Management
Opaleye Management holds 48 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Protara Therapeutics Com Stk (TARA) | 13.1 | $65M | 2.2M | 29.32 | |
| Ocular Therapeutix (OCUL) | 10.1 | $50M | 6.0M | 8.33 | |
| Neoleukin Therapeutics | 4.7 | $23M | 1.4M | 16.60 | |
| Chemocentryx | 4.2 | $21M | 362k | 57.57 | |
| Eton Pharmaceuticals (ETON) | 4.0 | $20M | 3.6M | 5.45 | |
| Aptose Biosciences Com New | 4.0 | $20M | 3.1M | 6.31 | |
| Codexis (CDXS) | 3.2 | $16M | 1.4M | 11.49 | |
| Stereotaxis Com New (STXS) | 3.2 | $16M | 3.5M | 4.46 | |
| Eidos Therapeutics | 3.0 | $15M | 316k | 46.38 | |
| Harrow Health (HROW) | 2.9 | $14M | 2.7M | 5.21 | |
| Myovant Sciences | 2.8 | $14M | 683k | 20.62 | |
| Macrogenics (MGNX) | 2.8 | $14M | 501k | 27.92 | |
| Celldex Therapeutics Com New (CLDX) | 2.8 | $14M | 1.1M | 13.00 | |
| Deciphera Pharmaceuticals | 2.6 | $13M | 222k | 58.92 | |
| Avenue Therapeutics Com New | 2.3 | $11M | 1.0M | 10.77 | |
| Odonate Therapeutics Ord | 2.1 | $11M | 250k | 42.34 | |
| Fortress Biotech | 2.1 | $10M | 3.8M | 2.68 | |
| Tg Therapeutics (TGTX) | 1.8 | $8.9M | 457k | 19.48 | |
| Kiniksa Pharmaceuticals Com Cl A | 1.8 | $8.8M | 345k | 25.48 | |
| Cerecor | 1.8 | $8.8M | 3.4M | 2.60 | |
| Vaxcyte SHS (QURE) | 1.7 | $8.5M | 270k | 31.61 | |
| Biohaven Pharmaceutical Holding | 1.7 | $8.4M | 114k | 73.11 | |
| Xoma Corp Del Com New (XOMA) | 1.7 | $8.2M | 415k | 19.76 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.5 | $7.6M | 435k | 17.52 | |
| Cytokinetics Com New (CYTK) | 1.4 | $7.1M | 303k | 23.57 | |
| Molecular Templates | 1.4 | $6.8M | 495k | 13.79 | |
| Tricida | 1.3 | $6.5M | 238k | 27.48 | |
| Chimerix (CMRX) | 1.3 | $6.5M | 2.1M | 3.10 | |
| Mei Pharma Com New | 1.3 | $6.4M | 1.6M | 4.13 | |
| Fibrogen | 1.1 | $5.7M | 146k | 38.96 | |
| Kalvista Pharmaceuticals (KALV) | 1.1 | $5.6M | 462k | 12.10 | |
| Catalyst Pharmaceutical Partners (CPRX) | 1.1 | $5.3M | 1.2M | 4.62 | |
| Bioxcel Therapeutics | 1.0 | $5.0M | 94k | 53.01 | |
| Edap Tms Sa Sponsored Adr (EDAP) | 0.9 | $4.6M | 1.9M | 2.47 | |
| Kala Pharmaceuticals | 0.8 | $3.8M | 361k | 10.51 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.7 | $3.6M | 971k | 3.69 | |
| Liquidia Technologies (LQDA) | 0.7 | $3.4M | 400k | 8.42 | |
| Ardelyx (ARDX) | 0.7 | $3.3M | 472k | 6.92 | |
| Tela Bio (TELA) | 0.7 | $3.2M | 250k | 12.96 | |
| Amarin Corp Sponsored Adr | 0.6 | $3.1M | 455k | 6.92 | |
| Cardiff Oncology (CRDF) | 0.6 | $3.0M | 590k | 5.01 | |
| Adamas Pharmaceuticals | 0.5 | $2.5M | 960k | 2.56 | |
| Fennec Pharmaceuticals (FENC) | 0.3 | $1.4M | 171k | 8.35 | |
| Essa Pharma Com New (EPIX) | 0.2 | $1.1M | 175k | 6.20 | |
| Autolus Therapeutics Sponsored Ads (AUTL) | 0.2 | $962k | 60k | 16.03 | |
| Assertio Holdings Ord | 0.2 | $754k | 880k | 0.86 | |
| Magenta Therapeutics | 0.1 | $385k | 51k | 7.52 | |
| Biolinerx Sponsored Ads | 0.0 | $29k | 17k | 1.74 |
